CDKL5 regulates p62-mediated selective autophagy and confers protection against neurotropic viruses.

Autophagy Cellular immune response Infectious disease Innate immunity Virology

Journal

The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877

Informations de publication

Date de publication:
02 Nov 2023
Historique:
medline: 2 11 2023
pubmed: 2 11 2023
entrez: 2 11 2023
Statut: aheadofprint

Résumé

Virophagy, the selective autophagosomal engulfment and lysosomal degradation of viral components, is crucial for neuronal cell survival and antiviral immunity. However, the mechanisms leading to viral antigen recognition and capture by autophagic machinery remain poorly understood. Here, we identified cyclin-dependent kinase-like 5 (CDKL5), known to function in neurodevelopment, as an essential regulator of virophagy. Loss of function mutations in CDKL5 are associated with a severe neurodevelopmental encephalopathy. We found deletion of CDKL5 or expression of a clinically-relevant pathogenic mutant of CDKL5 reduced virophagy of Sindbis virus (SINV), a neurotropic RNA virus, and increased intracellular accumulation of SINV capsid protein aggregates and cellular cytotoxicity. CDKL5 knockout mice displayed increased viral antigen accumulation and neuronal cell death after SINV infection and enhanced lethality after infection with several neurotropic viruses. Mechanistic studies demonstrated that CDKL5 directly binds the canonical selective autophagy receptor p62 and phosphorylates p62 at T269/S272 to promote its interaction with viral capsid aggregates. We found that CDKL5-mediated phosphorylation of p62 facilitated the formation of large p62 inclusion bodies that captured viral capsids to initiate capsid targeting to autophagic machinery. Overall, these findings identify a cell-autonomous innate immune mechanism for autophagy activation to clear intracellular toxic viral protein aggregates during infection.

Identifiants

pubmed: 37917202
pii: 168544
doi: 10.1172/JCI168544
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI130020
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI142784
Pays : United States

Auteurs

Josephine W Thinwa (JW)

Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, United States of America.

Zhongju Zou (Z)

Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, United States of America.

Emily Parks (E)

Department of Cell Biology, The University of Texas Southwestern Medical Center, Dallas, United States of America.

Salwa Sebti (S)

Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, United States of America.

Kelvin K Hui (KK)

Howard Hughes Medical Institute, The University of Texas Southwestern Medical Center, Dallas, United States of America.

Yongjie Wei (Y)

Affiliated Cancer Hospital and Institute, Guangzhou Medical University, Guangzhou, China.

Mohammad Goodarzi (M)

Department of Immunology, The University of Texas Southwestern Medical Center, Dallas, United States of America.

Vibha Singh (V)

Department of Immunology, The University of Texas Southwestern Medical Center, Dallas, United States of America.

Greg Urquhart (G)

Department of Molecular Biology, The University of Texas Southwestern Medical Center, Dallas, United States of America.

Jenna L Jewell (JL)

Department of Molecular Biology, The University of Texas Southwestern Medical Center, Dallas, United States of America.

Julie K Pfeiffer (JK)

Department of Microbiology, The University of Texas Southwestern Medical Center, Dallas, United States of America.

Beth Levine (B)

The University of Texas Southwestern Medical Center, Dallas, United States of America.

Tiffany A Reese (TA)

Department of Immunology, The University of Texas Southwestern Medical Center, Dallas, United States of America.

Michael U Shiloh (MU)

Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, United States of America.

Classifications MeSH